Logo image of BDX

BECTON DICKINSON AND CO (BDX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BDX - US0758871091 - Common Stock

201.52 USD
-1.22 (-0.6%)
Last: 1/13/2026, 8:04:00 PM
201.52 USD
0 (0%)
After Hours: 1/13/2026, 8:04:00 PM
Fundamental Rating

5

Overall BDX gets a fundamental rating of 5 out of 10. We evaluated BDX against 185 industry peers in the Health Care Equipment & Supplies industry. BDX has an excellent profitability rating, but there are some minor concerns on its financial health. BDX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BDX had positive earnings in the past year.
BDX had a positive operating cash flow in the past year.
In the past 5 years BDX has always been profitable.
Each year in the past 5 years BDX had a positive operating cash flow.
BDX Yearly Net Income VS EBIT VS OCF VS FCFBDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

The Return On Assets of BDX (3.03%) is better than 77.30% of its industry peers.
Looking at the Return On Equity, with a value of 6.61%, BDX belongs to the top of the industry, outperforming 80.54% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.24%, BDX is doing good in the industry, outperforming 79.46% of the companies in the same industry.
BDX had an Average Return On Invested Capital over the past 3 years of 5.64%. This is below the industry average of 8.84%.
The last Return On Invested Capital (6.24%) for BDX is above the 3 year average (5.64%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.03%
ROE 6.61%
ROIC 6.24%
ROA(3y)2.9%
ROA(5y)3.12%
ROE(3y)6.24%
ROE(5y)6.77%
ROIC(3y)5.64%
ROIC(5y)5.24%
BDX Yearly ROA, ROE, ROICBDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

With a decent Profit Margin value of 7.68%, BDX is doing good in the industry, outperforming 79.46% of the companies in the same industry.
In the last couple of years the Profit Margin of BDX has grown nicely.
BDX's Operating Margin of 15.70% is amongst the best of the industry. BDX outperforms 84.86% of its industry peers.
In the last couple of years the Operating Margin of BDX has grown nicely.
BDX's Gross Margin of 45.79% is on the low side compared to the rest of the industry. BDX is outperformed by 61.08% of its industry peers.
In the last couple of years the Gross Margin of BDX has remained more or less at the same level.
Industry RankSector Rank
OM 15.7%
PM (TTM) 7.68%
GM 45.79%
OM growth 3Y4.99%
OM growth 5Y10.71%
PM growth 3Y-4.96%
PM growth 5Y10%
GM growth 3Y0.22%
GM growth 5Y0.65%
BDX Yearly Profit, Operating, Gross MarginsBDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

4

2. Health

2.1 Basic Checks

BDX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BDX has less shares outstanding
Compared to 5 years ago, BDX has less shares outstanding
The debt/assets ratio for BDX has been reduced compared to a year ago.
BDX Yearly Shares OutstandingBDX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
BDX Yearly Total Debt VS Total AssetsBDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.2 Solvency

BDX has an Altman-Z score of 2.20. This is not the best score and indicates that BDX is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.20, BDX is doing good in the industry, outperforming 62.16% of the companies in the same industry.
BDX has a debt to FCF ratio of 7.18. This is a slightly negative value and a sign of low solvency as BDX would need 7.18 years to pay back of all of its debts.
The Debt to FCF ratio of BDX (7.18) is better than 75.68% of its industry peers.
BDX has a Debt/Equity ratio of 0.73. This is a neutral value indicating BDX is somewhat dependend on debt financing.
BDX has a worse Debt to Equity ratio (0.73) than 69.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 7.18
Altman-Z 2.2
ROIC/WACC0.66
WACC9.41%
BDX Yearly LT Debt VS Equity VS FCFBDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 1.11 indicates that BDX should not have too much problems paying its short term obligations.
BDX has a worse Current ratio (1.11) than 85.41% of its industry peers.
BDX has a Quick Ratio of 1.11. This is a bad value and indicates that BDX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.64, BDX is not doing good in the industry: 88.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.64
BDX Yearly Current Assets VS Current LiabilitesBDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.57% over the past year.
The Earnings Per Share has been growing slightly by 7.19% on average over the past years.
BDX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.24%.
BDX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.32% yearly.
EPS 1Y (TTM)9.57%
EPS 3Y5.64%
EPS 5Y7.19%
EPS Q2Q%3.94%
Revenue 1Y (TTM)8.24%
Revenue growth 3Y4.99%
Revenue growth 5Y6.32%
Sales Q2Q%8.33%

3.2 Future

The Earnings Per Share is expected to grow by 6.59% on average over the next years.
Based on estimates for the next years, BDX will show a small growth in Revenue. The Revenue will grow by 3.38% on average per year.
EPS Next Y4.14%
EPS Next 2Y5.2%
EPS Next 3Y5.3%
EPS Next 5Y6.59%
Revenue Next Year2.92%
Revenue Next 2Y3.14%
Revenue Next 3Y3.18%
Revenue Next 5Y3.38%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BDX Yearly Revenue VS EstimatesBDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BDX Yearly EPS VS EstimatesBDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.98, the valuation of BDX can be described as correct.
Based on the Price/Earnings ratio, BDX is valued cheaper than 90.81% of the companies in the same industry.
BDX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 13.42, BDX is valued correctly.
Based on the Price/Forward Earnings ratio, BDX is valued cheaper than 90.81% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.04. BDX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.98
Fwd PE 13.42
BDX Price Earnings VS Forward Price EarningsBDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BDX is valued cheaply inside the industry as 86.49% of the companies are valued more expensively.
88.11% of the companies in the same industry are more expensive than BDX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.54
EV/EBITDA 12.82
BDX Per share dataBDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BDX may justify a higher PE ratio.
PEG (NY)3.37
PEG (5Y)1.94
EPS Next 2Y5.2%
EPS Next 3Y5.3%

6

5. Dividend

5.1 Amount

BDX has a Yearly Dividend Yield of 2.05%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.19, BDX pays a better dividend. On top of this BDX pays more dividend than 96.76% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, BDX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.05%

5.2 History

The dividend of BDX has a limited annual growth rate of 3.22%.
BDX has been paying a dividend for at least 10 years, so it has a reliable track record.
BDX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.22%
Div Incr Years34
Div Non Decr Years34
BDX Yearly Dividends per shareBDX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

BDX pays out 71.28% of its income as dividend. This is not a sustainable payout ratio.
BDX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP71.28%
EPS Next 2Y5.2%
EPS Next 3Y5.3%
BDX Yearly Income VS Free CF VS DividendBDX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
BDX Dividend Payout.BDX Dividend Payout, showing the Payout Ratio.BDX Dividend Payout.PayoutRetained Earnings

BECTON DICKINSON AND CO

NYSE:BDX (1/13/2026, 8:04:00 PM)

After market: 201.52 0 (0%)

201.52

-1.22 (-0.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)01-29 2026-01-29
Inst Owners94.4%
Inst Owner Change0.02%
Ins Owners0.36%
Ins Owner Change4.25%
Market Cap57.52B
Revenue(TTM)21.84B
Net Income(TTM)1.68B
Analysts72.22
Price Target209.03 (3.73%)
Short Float %1.7%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Yearly Dividend4.16
Dividend Growth(5Y)3.22%
DP71.28%
Div Incr Years34
Div Non Decr Years34
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.54%
Min EPS beat(2)-0.05%
Max EPS beat(2)7.13%
EPS beat(4)3
Avg EPS beat(4)5.56%
Min EPS beat(4)-0.05%
Max EPS beat(4)14.05%
EPS beat(8)7
Avg EPS beat(8)5.42%
EPS beat(12)10
Avg EPS beat(12)4.67%
EPS beat(16)13
Avg EPS beat(16)5.77%
Revenue beat(2)0
Avg Revenue beat(2)-0.9%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)-0.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.99%
Min Revenue beat(4)-2.51%
Max Revenue beat(4)0.37%
Revenue beat(8)2
Avg Revenue beat(8)-0.95%
Revenue beat(12)5
Avg Revenue beat(12)-0.43%
Revenue beat(16)6
Avg Revenue beat(16)-0.46%
PT rev (1m)0.58%
PT rev (3m)-5.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.34%
EPS NY rev (1m)0.09%
EPS NY rev (3m)0.06%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-4.53%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-1.59%
Valuation
Industry RankSector Rank
PE 13.98
Fwd PE 13.42
P/S 2.63
P/FCF 21.54
P/OCF 16.77
P/B 2.27
P/tB N/A
EV/EBITDA 12.82
EPS(TTM)14.42
EY7.16%
EPS(NY)15.02
Fwd EY7.45%
FCF(TTM)9.35
FCFY4.64%
OCF(TTM)12.02
OCFY5.96%
SpS76.52
BVpS88.96
TBVpS-37.23
PEG (NY)3.37
PEG (5Y)1.94
Graham Number169.89
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 6.61%
ROCE 7.29%
ROIC 6.24%
ROICexc 6.33%
ROICexgc 26.66%
OM 15.7%
PM (TTM) 7.68%
GM 45.79%
FCFM 12.23%
ROA(3y)2.9%
ROA(5y)3.12%
ROE(3y)6.24%
ROE(5y)6.77%
ROIC(3y)5.64%
ROIC(5y)5.24%
ROICexc(3y)5.8%
ROICexc(5y)5.4%
ROICexgc(3y)27.15%
ROICexgc(5y)27.08%
ROCE(3y)6.53%
ROCE(5y)6.07%
ROICexgc growth 3Y-3.96%
ROICexgc growth 5Y9.78%
ROICexc growth 3Y7.94%
ROICexc growth 5Y16.75%
OM growth 3Y4.99%
OM growth 5Y10.71%
PM growth 3Y-4.96%
PM growth 5Y10%
GM growth 3Y0.22%
GM growth 5Y0.65%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 7.18
Debt/EBITDA 3.14
Cap/Depr 30.87%
Cap/Sales 3.48%
Interest Coverage 5.46
Cash Conversion 58.23%
Profit Quality 159.12%
Current Ratio 1.11
Quick Ratio 0.64
Altman-Z 2.2
F-Score7
WACC9.41%
ROIC/WACC0.66
Cap/Depr(3y)33.59%
Cap/Depr(5y)39.6%
Cap/Sales(3y)3.86%
Cap/Sales(5y)4.6%
Profit Quality(3y)162.63%
Profit Quality(5y)151.73%
High Growth Momentum
Growth
EPS 1Y (TTM)9.57%
EPS 3Y5.64%
EPS 5Y7.19%
EPS Q2Q%3.94%
EPS Next Y4.14%
EPS Next 2Y5.2%
EPS Next 3Y5.3%
EPS Next 5Y6.59%
Revenue 1Y (TTM)8.24%
Revenue growth 3Y4.99%
Revenue growth 5Y6.32%
Sales Q2Q%8.33%
Revenue Next Year2.92%
Revenue Next 2Y3.14%
Revenue Next 3Y3.18%
Revenue Next 5Y3.38%
EBIT growth 1Y18.62%
EBIT growth 3Y10.23%
EBIT growth 5Y17.71%
EBIT Next Year20.6%
EBIT Next 3Y11.99%
EBIT Next 5Y12.28%
FCF growth 1Y-13.11%
FCF growth 3Y17.14%
FCF growth 5Y-0.73%
OCF growth 1Y-9.69%
OCF growth 3Y9.2%
OCF growth 5Y-0.62%

BECTON DICKINSON AND CO / BDX FAQ

Can you provide the ChartMill fundamental rating for BECTON DICKINSON AND CO?

ChartMill assigns a fundamental rating of 5 / 10 to BDX.


What is the valuation status for BDX stock?

ChartMill assigns a valuation rating of 6 / 10 to BECTON DICKINSON AND CO (BDX). This can be considered as Fairly Valued.


How profitable is BECTON DICKINSON AND CO (BDX) stock?

BECTON DICKINSON AND CO (BDX) has a profitability rating of 7 / 10.


What is the valuation of BECTON DICKINSON AND CO based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BECTON DICKINSON AND CO (BDX) is 13.98 and the Price/Book (PB) ratio is 2.27.


What is the financial health of BECTON DICKINSON AND CO (BDX) stock?

The financial health rating of BECTON DICKINSON AND CO (BDX) is 4 / 10.